Recent RNA-sequencing data compared primary and recurrent DSRCT samples as well as cell lines suggesting the EWSR1::WT1 fusion protein as a principal driver with enrichment in genes regulated by the fusion protein in the recurrent versus primary tumor [6]. This evidence concerns the gene WT1 and neoplasm.